Dental Biomaterials Market

Global Dental Biomaterials Market Size (2023 to 2028)

The global market size for the dental biomaterials market is expected to be growing at a CAGR of 7.12% from 2023 to 2028 and be worth USD 13.31 billion by 2028 from USD 9.43 billion in 2023.

Impact of COVID-19 on the global dental biomaterials market:

The COVID-19 pandemic significantly negatively impacted the growth of the dental biomaterials market in the initial days.

The COVID-19 pandemic significantly affected the market because it forced the suspension or postponement of several elective procedures, including dental treatments. The American Dental Association (ADA) suggested in March 2020 delaying all elective dental procedures until April 6, 2020, and only offering emergency dental care to prevent patients from overtaxing hospital emergency rooms. Due to an increase in COVID-19 cases, the ADA updated this advice on April 1, 2020, advising offices to remain closed until April 30 other than for urgent and emergency procedures. Access to dental care consequently significantly decreased. According to data published by the British Dental Association, only 1/3^rd of dental professionals were ready to resume their operations in the United Kingdom as of July 2020. Delays in dental services and treatments during the pandemic's early stages led to a decline in demand for dental biomaterials, which had a negative impact on the market expansion. However, the market is expanding due to the global resumption of elective dental procedures and the declining severity and infections of COVID-19.

MARKET DRIVERS:

The growing dental tourism in emerging markets, an increase in the geriatric population, and an increase in the prevalence of dental disorders are primarily boosting the development of the dental biomaterials market.

According to the World Health Organization (WHO) statistics, one in every six people is expected to be more than 60 years old by 2030. Therefore, the dental tourism market worldwide is anticipated to showcase a CAGR of 12.4% from 2022 to 2027. Oral health has now become one of the significant concerns among people, and an estimated 3.5 people suffer from dental problems.

The rising oral disorder prevalence, growing awareness, and increasing disposable income are further estimated to boost the growth rate of the dental biomaterials market.

The incidence of various oral disorders is growing significantly worldwide, boosting the demand levels for dental biomaterials at the same pace. Dental biomaterials are very effective, with a potential success rate in treating and preventing oral diseases. Patients with oral disorders undergo various elective procedures as a result. This factor is anticipated to fuel the market for dental biomaterials globally.

Furthermore, throughout the forecast period, the growth of the dental biomaterials market is estimated to be aided by rising awareness of the value of dental implants in middle- and low-income nations. In addition, as disposable income has grown in developed countries, so has the demand for aesthetic procedures such as teeth whitening and gum contouring. Throughout the forecast period, this trend is anticipated to support market expansion.

MARKET RESTRAINTS:

On the other hand, the high costs of dental biomaterials and the stringent guidelines during approval by the FDA, various difficulties faced during the clinical trials, manufacturing, and production due to limited expertise in the field and a lack of skilled professionals, and unfavorable return policies are expected to hinder the growth of the dental biomaterials market.

REPORT COVERAGE:

This research report on the global dental biomaterials market has been segmented based on the type, application, end-user, and region.

Dental Biomaterials Market – By Type:

• Metallic Biomaterials
  • Titanium
  • Stainless Steel
  • Chromium Alloys
  • Others
• Ceramic Biomaterials
• Polymeric Biomaterials
• Metal-Ceramic Biomaterials
• Natural Biomaterials
• Composites Biomaterials

Based on type, the metallic biomaterials segment led the market in 2022, and the domination is anticipated to continue throughout the forecast period. Metallic biomaterials are a crucial class of materials used in dental procedures. The growth of this segment can be attributed to the high strength and other mechanical characteristics of these materials. Due to their ability to withstand loads and resist fatigue, biomaterials like silicon, gallium, and titanium are frequently used to create surgical implants. Furthermore, the metallic dental biomaterials segment is expected to grow due to the expanding popularity of dental implants and procedures. Due to the aging geriatric populations in developed countries and patients' desire to maintain their engagement and standard of living, the use of implants has significantly increased in recent years. As a result, the use of superior implantable biomaterials that can address particular dental problems has steadily increased.

Dental Biomaterials Market – By Application:

• Implantology
• Orthodontics
• Prosthodontics

Based on the application, the orthodontics segment led the dental biomaterials market with the highest share of 44.8% in 2022. The dominance of this segment is attributed to the rise in dental conditions and tooth decays, and there is a growing need for dental biomaterials in orthodontics. Additionally, rising disposable income and the trend toward medical tourism propel this market's expansion globally. Furthermore, due to the increasing popularity of dental implants, the market for dental biomaterials for orthodontics is also expanding.

Besides, the implantology segment is anticipated to grow at the fastest CAGR during the forecast period. Dentistry's field of implantology focuses on the long-term implantation of prosthetic teeth in the jaw. Dental implants or implantology use a variety of biomaterials. Additionally, the growth of the global market for dental biomaterials for implantology is driven by cosmetic dentistry's rising popularity.

Dental Biomaterials Market – By End-User:

• Dental Implant and Prosthetic Manufacturers
• Dental Laboratories
• Dental Hospitals & Clinics
• Dental Academies & Research Institutes

During the forecast period, the market for dental biomaterials is anticipated to be dominated by the dental laboratories segment. Dental biomaterials for dental laboratories are expanding as a result of factors including rising dental diseases and infections, growing consumer awareness of oral hygiene and health, and increasing demand for dental implants and procedures. Correspondingly, expanding research and development activities worldwide are also credited with contributing to the global dental biomaterials market growth.

Dental Biomaterials Market – By Region:

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Geographically, North America held a dominant position in the global dental biomaterials market in 2022, owing to the presence of the most sophisticated healthcare infrastructure, the rising prevalence of dental diseases, the increase in the geriatric population, and the rising healthcare costs. For instance, according to the American Dental Association, nearly 3 million US seniors aged 65 to 74 had no teeth by 2020, and more than 5 million had complete tooth loss. On the other hand, tooth loss primarily affects older people. This is due to the startling 27% of untreated dental caries that affect 91% of adults between the ages of 20 and 64. Additionally, tooth decay is frequently a factor in tooth loss. Therefore, it is anticipated that these factors will increase the overall number of dental procedures carried out in the United States, increasing the demand for dental biomaterials nationwide.

Over the forecast period, the Asia Pacific region is predicted to have the highest CAGR due to increased dental treatment and medical tourism. Furthermore, the rising geriatric population, rising occurrence of oral and tooth diseases, rising awareness of dental issues, and rising healthcare costs are all positively affecting the expansion of the dental market in the area.

Europe is another region expected to see a rise in the market for oral biologics in the forecast period. This growth is attributed to the rising geriatric population, rising public spending on oral healthcare, increased use of dental biomaterials in producing implants and other dental products, and expanding dental hospitals and clinics. Countries like Germany, the U.K., Mexico, France, Italy, Spain, etc., are participating in the market's growth. The U.K is likely to witness a significant share in the market during the forecast period. This is because of a supportive government, advancing healthcare sectors, and increasing research and development activities.

KEY MARKET PARTICIPANTS:

Straumann Holding AG, Geistlich Pharma AG, Zimmer Biomet Holdings, Inc., Danaher Corporation, Dentsply Sirona, Inc., 3M Company, Royal DSM, Carpenter Technology Corporation, Kuraray Co., Ltd., and Henry Schein, Inc. are a few of the companies playing a notable role in the global dental biomaterials market profiled in this report.

RECENT HAPPENINGS IN THIS MARKET:

• In May 2022, the Straumann Group acquired PlusDental, a German teledentistry business specializing in offering European orthodontic solutions. Straumann's doctor-led orthodontic segment has grown in size due to this acquisition, opening up new opportunities for market expansion. In addition, many people in the Netherlands, Sweden, and the UK now have access to dental care facilities thanks to PlusDental. During the forecast period, this development aids the market's overall growth.
• In February 2022, an endodontic product called MTApex bioceramic root canal sealer was launched by Ultradent Products Inc. Any endodontic obturation technique can be used with the bioceramic sealer MTApex.
• In 2018, the Straumann Group paid an undisclosed price for a 30% investment in Botiss Medical AG, a biomaterials partner. Due to this acquisition, Straumann will be able to increase its dental biomaterials portfolio.
• Carestream Dental, LLC introduced a new e-commerce website in September 2019 that includes accurate digital imaging, lower radiation levels during imaging, and paperless work.
• Align Technology, Inc. released the iTero element foundation intraoral scanner with restorative software in January 2019.
• Intra-Lock (Spain), a provider of dental restorative products, was acquired by Henry Schein, Inc. in 2018. This strengthens its position in the high-end implant market.